Azeliragon dihydrochloride (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression with mild Alzheimers disease (AD)[1]. Azeliragon dihydrochloride also can cross the blood-brain barrier (BBB)[2].
Molekulargewicht:
605.04
CAS Nummer:
[1284150-65-7]
Formel:
C32H40Cl3N3O2
Target-Kategorie:
Amyloid-beta
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten